Commentary: How foreign aid for medicine yields big economic returns

President Joe Biden’s decision to donate 500 million COVID-19 vaccines to other countries by June 2022 is an important step toward restoring the United States’ global standing. Another, parallel foreign policy solution could perhaps do even more. It is simple, cost-effective and could improve the health and well-being of billions of people — especially children.

Commentary: To heal the ocean, we must act fast

For millions of years, Earth’s climate has been fairly stable largely due to the ocean’s role in mediating global temperature and driving our weather cycles, determining rainfall, storms, droughts and floods. Without much attention or support from humans, the ocean has been protecting every living being on this planet from the harmful effects of climate change by absorbing and redistributing heat across the planet through its currents.

Editorial: Biden’s vaccine goal of 70% by July 4 could pass us by, and we have no one to blame but ourselves

It wasn’t that long ago that people were clamoring for COVID-19 vaccines, with some going as far as lying about their age to secure the much-in-demand but not readily available shots — back when they were meted out by age, oldest first. Now the country is in a whole other, opposite dilemma with plenty of vaccines to go around, but not enough willing people waving their arms to get them. The concern is so great that governments, including Maryland’s, and businesses are trying to entice people with incentives such as food, cash and lottery winnings.

Editorial: Biden should be better at seeing what’s ahead

In 2012, Pew Research asked 1,008 Americans to describe then-Vice President Joe Biden in one word. The responses ranged from “Good,” the most common answer, to “Goofy.” But almost five months into his tenure, the word that perhaps most accurately describes him as president is “Shortsighted.” Time after time, Biden has been caught short by consequences of his policies that should have been obvious.

Editorial: New drug for Alzheimer’s: Sound science or profit-driven?

The announcement of a new drug to treat Alzheimer’s disease was greeted this week with celebration and skepticism. The Food and Drug Administration approved the use of the drug Aduhelm over the objections of an FDA advisory committee and expert panels that questioned the medicine’s effectiveness in trials.

Will you have fewer friends after lockdown?

As many countries tentatively loosen their corona restrictions, some of us are feeling anxious. Have my social skills gotten rusty from long quarantines and lockdowns? Have my friendships gone stale? Will I still have my old clique to return to? Have my social circles frayed or shrunk?

Editorial: Federal regulators and Mattel failed miserably while infants died in an inclined sleeper

A report released Monday by House Oversight Committee Chair Carolyn Maloney delivers a rude awakening to Fisher-Price and the federal government — which for nearly a decade looked the other way even as dozens of infants died in a product marketed for napping and overnight sleeping. Deepest shame on the company and its parent, Mattel, for putting profits over safety, and on the feds for taking years to snap out of their own deadly slumber.